BDBM542000 US11273153, Compound 4.18

SMILES Fc1ccc(cc1)-c1scc(CCCc2ccccc2)c1-c1ccncc1

InChI Key InChIKey=KSRFHPNSMBSQRE-UHFFFAOYSA-N

Data  4 KI  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 542000   

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542000(US11273153, Compound 4.18)
Affinity DataIC50: 270nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542000(US11273153, Compound 4.18)
Affinity DataIC50: 270nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542000(US11273153, Compound 4.18)
Affinity DataKi:  720nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542000(US11273153, Compound 4.18)
Affinity DataKi:  720nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542000(US11273153, Compound 4.18)
Affinity DataKi:  1.50E+3nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542000(US11273153, Compound 4.18)
Affinity DataKi:  1.50E+3nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
US Patent